Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Reezwana Chowdhury"'
Autor:
Sonmoon Mohapatra, Kesavan Sankaramangalam, Chawin Lopimpisuth, Oluwatoba Moninuola, Malorie Simons, Julie Nanavati, Leah Jager, Debra Goldstein, Arkady Broder, Venkata Akshintala, Reezwana Chowdhury, Alyssa Parian, Mark G. Lazarev, Saowanee Ngamruengphong
Publikováno v:
Endoscopy International Open, Vol 10, Iss 05, Pp E593-E601 (2022)
Background and study aims Little is known about outcomes of advanced endoscopic resection (ER) for patients with inflammatory bowel disease (IBD) with dysplasia. The aim of our meta-analysis was to estimate the safety and efficacy of endoscopic mucos
Externí odkaz:
https://doaj.org/article/2c1037e8ee2a4f88820c8da2d960682c
Autor:
Marcus Messmer, Sunita Upreti, Yaman Tarabishy, Nikhilesh Mazumder, Reezwana Chowdhury, Mark Yarchoan, Matthias Holdhoff
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 705-713 (2016)
Introduction: Ipilimumab is an immune checkpoint inhibitor targeting cytotoxic T-lymphocyte associated antigen 4 (CTLA4), approved to treat metastatic melanoma. It was the first therapy shown to prolong survival in a large, randomized clinical trial.
Externí odkaz:
https://doaj.org/article/247fbc43269f45c6b312208e82b421a7
Autor:
Evangelos, Tsipotis, Sarah, Frey, Caoilfhionn, Connolly, William A, Werbel, Reezwana, Chowdhury, Sharon, Dudley-Brown, Joanna M, Melia, Alyssa M, Parian, Brindusa, Truta, Huimin, Yu, Florin M, Selaru, Dorry L, Segev, Mark, Lazarev
Publikováno v:
American Journal of Gastroenterology. 117:798-801
The response to SARS-CoV-2 vaccination of patients with inflammatory bowel disease (IBD) on immune-modifying therapies requires further investigation because previous studies indicate that patients on immune therapy might have decreased antibody conc
Autor:
Reezwana Chowdhury, Sunanda V. Kane
Publikováno v:
Alimentary Pharmacology & Therapeutics. 57:349-350
Autor:
Reezwana Chowdhury, Sunanda V Kane
Publikováno v:
Gastroenterology Report. 10
Approximately 50% of patients with inflammatory bowel disease including both Crohn’s disease and ulcerative colitis are female with many being diagnosed and treated during their reproductive years. It is important for women to be in remission prior
Autor:
Evangelos Tsipotis, Reezwana Chowdhury, Sharon Dudley-Brown, Mark Lazarev, Joanna Melia, Alyssa Parian, Florin M. Selaru, Huimin Yu, Brindusa Truta
Publikováno v:
Gastroenterology. 162:S-292
Autor:
George Salem, Cristian Hernandez-Rocha, Reezwana Chowdhury, Laura A. Maas, Simon J. Hong, James Conner, Mark S. Silverberg, Sharon Dudley-Brown, Joanna Melia, Alyssa Parian, Florin M. Selaru, Brindusa Truta, Huimin Yu, Mark Lazarev
Publikováno v:
Gastroenterology. 162:S-434
Autor:
Reezwana, Chowdhury, Sunanda, Kane
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 52(8)
Autor:
Florin M. Selaru, George Salem, Reezwana Chowdhury, Gala Godoy Brewer, Alyssa Parian, Berkeley N. Limketkai, Joanna Melia, Katie A. Falloon, Mark Lazarev
Publikováno v:
Inflammatory bowel diseases. 27(9)
Background Patients with long-standing ulcerative colitis (UC) are at an increased risk of colorectal cancer. Risk stratification is important to identify patients who require more frequent endoscopic surveillance. Serrated epithelial change (SEC) fo
Publikováno v:
American Journal of Gastroenterology. 116:S599-S599